Search Results
Baxter and VIPUN Medical Announce Collaboration to Commercialize Innovative Gastric Monitoring System to Help Enhance Clinical Nutrition
Baxter International Inc. (NYSE: BAX), a global leader in clinical nutrition, and VIPUN Medical, a company developing technology solutions to help improve medical nutrition, today announced an agreement to commercialize the VIPUN Gastric Monitoring System.
Baxter Ranks in Top 10% on Disability Equality Index
Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today it has been named a top-scoring company on the 2020 Disability Equality Index® (DEI) by Disability:IN, the leading nonprofit resource for business disability inclusion worldwide. The company's 90% score places it in the top 10% of all companies in the index and earns the "Best Place to Work for Disability Inclusion" recognition.
Baxter Declares Quarterly Dividend
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.245 per share of common stock. The dividend is payable on October 1, 2020, to shareholders of record as of August 31, 2020. The indicated annual dividend rate is $0.98 per share of common stock. About Baxter
Baxter Announces U.S. FDA Clearance of Altapore Shape Bioactive Bone Graft for Use in Surgery
Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced U.S. Food and Drug Administration (FDA) clearance of Altapore Shape Bioactive Bone Graft, the latest addition to the company’s next-generation bone graft substitute product line. Altapore Shape is designed to enhance bone growth and help achieve fusion, which can lead to reduced pain and other improved clinical outcomes for patients.
Baxter to Host Second-Quarter 2020 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its second-quarter 2020 financial results on Thursday, July 30, 2020, at 7:30 a.m. Central Time. To access the call, dial (844) 471-1702 (domestic) or (574) 990-3603 (international). Please dial into the call at least ten minutes prior to the start for the operator to connect you. The Conference ID is 2386827.
Baxter Publishes 2019 Corporate Responsibility Report, Highlighting Efforts to Make a Meaningful Difference as a Leading Global Corporate Citizen
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today released its 2019 Corporate Responsibility Report.
Baxter Highlights New Data on the Role Technologies Play in Improving Care for Dialysis Patients During the 57th ERA-EDTA Virtual Congress
Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced new data showing use of Baxter’s Sharesource remote patient management (telehealth) platform for automated peritoneal dialysis (APD) therapy performed in Colombia was associated with a 56% reduction in technique failure.
Baxter Senior Leadership Team Commitment to Addressing Racial Injustice
Our focus on Inclusion & Diversity (I&D) at Baxter has never been more compelling or urgent. Racism has been a longstanding and disturbing societal issue, and recent displays of racial injustice toward the Black community have rocked U.S. society to its core – with the impact resonating far beyond. The events are all the worse for playing out against a pandemic that’s compounding health and economic disparities globally.
Baxter to Present at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast on Tuesday, June 9, 2020. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 9:40 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through June 9, 2021.
